GRIP Molecular is a company headquartered in the United States.
GRIP Molecular develops a molecular diagnostic platform using a CRISPR protease engine to rapidly detect pathogens such as bacteria, viruses, and fungi with molecular-grade accuracy in point-of-care and point-of-need settings.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.